Andrew Grossman, MD, Honored by Crohn’s and Colitis Foundation (CCF)

Published on

Andrew Grossman, MD Andrew Grossman, MD Andrew Grossman, MD, attending physician in the Division of Gastroenterology, Hepatology and Nutrition and co-director of CHOP's Center for Pediatric Inflammatory Bowel Disease (IBD), recently received a Gold Medallion Award from the Crohn’s and Colitis Foundation (CCF) at their Evening of Hope Gala. Dr. Grossman was selected for his excellence in treating patients with IBD and his long-standing support of the CCF.

“Being an honoree of the Crohn’s and Colitis Foundation is one of the biggest honors of my career,” said Dr. Grossman. “I’ve been on their local board for almost eight years and involved in the scientific advisory committee at the local level for almost two years. Today I serve as chair of the pediatric affairs committee for the national organization.”

“I met Dr. Grossman not long after I was diagnosed,” say his patient, Kristen. “He has been a rock, and made a lot of what I’ve gone through easier because he’s easy to relate to, easy to talk to and he’s easy to reach.”

“I had just started my fellowship and Kristen was one of my first patients, so we have gone through this journey together” adds Dr. Grossman.

“We have an opportunity to understand these diseases better, understand how to treat them better and much of the funding for these studies comes from the CCF. We feel very fortunate to partner with them as we work to find better treatments, and ultimately a cure for IBD,” added Dr. Grossman.

The Center for Pediatric Inflammatory Bowel Disease at CHOP is one of the largest and most advanced centers of its kind in the U.S. CHOP’s multi-specialty team consists of dedicated IBD pediatric gastroenterologists, dietitians, and nurse educators, as well as intensive support from a team of social workers and psychologists. The Center features a Very Early Onset IBD program, a clinical and research program uncovering underlying genetic and immunologic reasons that may contribute to the development of the disease and may help with providing new treatment options.